Export Opportunity Helena's recognition with the U.S. Commerce 'E' Award underscores a strong export orientation. With a diversified client base spanning major medical centers, hospitals, and private labs, there is a structured path to formalize international distribution and expand reagent and instrument offerings into Europe and other regions where regulatory and service networks can be established.

Field Sales Strength A dedicated field force of around 75 specialists provides direct access to customers for instrument deployments, maintenance, and reagent programs, enabling accelerated cross-sell of new diagnostic tests and bundled service agreements.

IP and Innovation A robust patent portfolio and ongoing product development create differentiation in diagnostic tests; opportunities exist to upsell new assays and bundled reagent kits to existing hospital networks.

Major Account Focus Serving major medical centers and laboratories suggests targeted enterprise deals, multi-site procurement, and long-term service contracts; propose enterprise-wide reagent supply agreements, instrument uptime services, and training packages across networks.

Procurement Cycle Shift A leadership transition in finance could trigger updated procurement cycles; this is an opportunity to accelerate engagement with procurement teams on pricing, terms, and pilot programs ahead of budget planning.